Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Anti-Viral Central Memory CD8 Veto Cells by Cell Source for Sickle Cell Disease: Likelihood of Approval
Anti-Viral Central Memory CD8 Veto Cells is under clinical development by Cell Source and currently in Phase II for Sickle...